Irazu Oncology
PrivateLast Round
Seed
Jul 7, 2026
Total Funding Raised
$3.15M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Irazu Oncology is a biotechnology company that develops next-generation cancer immunotherapies using a proprietary Outer Membrane Vesicles (OMV) platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Irazu Oncology Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Irazu Oncology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 7, 2026 | ||||
| Series A | Mar 4, 2025 | ||||
| VC Round | Mar 4, 2025 | ||||
| Seed | Dec 19, 2023 | ||||
| Grant | Aug 28, 2023 |
Key People
Founding team and executive leadership
Irazu Oncology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Abell Foundation | Seed |
| TEDCO | Seed, VC Round, Grant |
| Wexford Science & Technology | Seed |
| University System of Maryland Momentum Fund | Seed |
| University of Maryland, Baltimore | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 19, 2026
Monthly visitors grew 50% MoM to 1.3K.
- Mar 4, 2025
$500K round led by TEDCO.
Irazu Oncology Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Irazu Oncology's valuation, stock price, and market status.